Impact of monotherapy on HIV-1 reservoir, immune activation, and co-infection with Epstein-Barr virus-Reference-Cited by-同舟云学术

Impact of monotherapy on HIV-1 reservoir, immune activation, and co-infection with Epstein-Barr virus

Published:2017-09-19 Issue:9 Volume:12 Page:e0185128
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Petrara Maria Raffaella,Cattelan Anna Maria,Sasset Lolita,Freguja Riccardo,Carmona Francesco,Sanavia Silvia,Zanchetta Marisa,Del Bianco Paola,De Rossi Anita^ORCID

Funder

Associazione Italiana per la Ricerca sul Cancro

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference36 articles.

1. HIV monotherapy with ritonavir-boosted protease inhibitors: a systematic review;WF Bierman;AIDS,2009

2. Effectiveness of protease inhibitor monotherapy versus combination antiretroviral maintenance therapy: a meta-analysis;S Mathis;PLoS One,2011

3. Efficacy of protease inhibitor monotherapy vs. triple therapy: meta-analysis of data from 2303 patients in 13 randomized trials;JR Arribas;HIV Med,2016

4. The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/ml;JR Arribas;AIDS,2010

5. Efficacy of darunavir/ritonavir maintenance monotherapy in patients with HIV-1 viral suppression: a randomized open-label, noninferiority trial, MONOI-ANRS 136;C Katlama;AIDS,2010

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune Activation, Exhaustion and Senescence Profiles as Possible Predictors of Cancer in Liver Transplanted Patients;Frontiers in Oncology;2022-06-13

2. Management of Comorbidities in Treated HIV Infection: A Long Way to Go;International Journal of Antimicrobial Agents;2022-01

3. Dual Antiretroviral Therapy—All Quiet Beneath the Surface?;Frontiers in Immunology;2021-02-12

4. Epidemiological features of Epstein-Barr virus infection;Sanitarnyj vrač (Sanitary Doctor);2020-09-01

5. Viruses and oral diseases in HIV‐infected individuals on long‐term antiretroviral therapy: What are the risks and what are the mechanisms?;Oral Diseases;2020-08-30